Form 4: CONMED Corp Executive Granted Stock Options

Todd W. Garner, Executive Vice President & CFO of CONMED Corp, was granted 44,677 stock options on March 1, 2024, under the company's 2018 Long-Term Incentive Plan.

Summary

• Todd W. Garner, Executive Vice President & CFO of CONMED Corp, was granted 44,677 stock options on March 1, 2024.
• The options were granted under the company's 2018 Long-Term Incentive Plan.
• The exercise price of the options is $79.95.
• The options generally vest in equal amounts over a five-year period.
• Garner also has a Power of Attorney agreement in place, effective September 13, 2023, allowing designated attorneys to handle SEC filings on his behalf.

Sentiment

Score: 6

Explanation: The document is a routine SEC filing related to executive compensation. It is neutral in tone and reflects standard corporate governance practices.

Positives

• The grant of stock options aligns the executive's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the executive.
• The Power of Attorney ensures timely and accurate SEC filings.

Future Outlook

The document does not contain any specific forward-looking statements regarding the company's future performance.

Industry Context

Stock option grants are a common form of executive compensation in the medical technology industry, aligning management's interests with shareholder value creation.

Comparison to Industry Standards

• Stock option grants are a standard component of executive compensation packages in publicly traded companies, particularly in the medical device industry.
• Companies like Stryker, Medtronic, and Boston Scientific also utilize stock options as part of their executive compensation plans.
• The vesting schedule of five years is fairly typical for such grants, designed to incentivize long-term performance and retention.

Stakeholder Impact

• The stock option grant could potentially increase shareholder value if the executive's performance leads to an increase in the company's stock price.
• Employees may view the grant as a positive sign of the company's commitment to its leadership.

Key Dates